A Aralex Aachen research explorer

Search

From

To

Institution

Field

Type

Open access only Cited by patents (Lens) Include non-Aachen papers (citing/cited)

Papers matching “BRCAness” 4

Sort: Relevance Cited Newest Oldest Fwci Patents ⇩ CSV

Not finding it? Sign in to also search OpenAlex live.

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107
2025 Molecular Oncology article Medicine PARP inhibition in cancer therapy Open access

Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Anne Stoffel, Bianca Faßbender, +8 more

1

citations
Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107
2025 Molecular Oncology article Medicine PARP inhibition in cancer therapy Open access

Anna L. Bartkowiak, Nora Kolks, Patrick Petzsch, Anne Stoffel, Bianca Faßbender, Leandra Lepping, +7 more

0

citations
Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR− Trial
2022 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access

Monika Graeser, Oleg Gluz, Claudia Biehl, Daniel Ulbrich-Gebauer, Matthias Christgen, Jenci Palatty, +21 more

14

citations
Data from Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR− Trial
2023 other Medicine HER2/EGFR in Cancer Research Open access

Monika Graeser, Oleg Gluz, Claudia Biehl, Daniel Ulbrich-Gebauer, Matthias Christgen, Jenci Palatty, +21 more

0

citations

4 results